Sort
85,873 grants matching “alzheimers”
Mechanisms of Alzheimer's Disease Progression in the Aging Brain
$845,658William J. Jagust · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2020 · AG
Pathogenesis of Neurological Disability in Primary Diseases of Myelin
$845,598Bruce D Trapp · Cleveland Clinic Lerner Com-Cwru · R35 · FY2024 · NS
Application of ambulatory methods for assessing short- and long-term associations of sleep health with cognitive decline in older adults
$845,526Carol A Derby · Albert Einstein College Of Medicine · R01 · FY2019 · AG
Role of age, dopamine, and tau related network disruption in setting a context for progression toward Alzheimer's disease
$845,498Julius C Hedden · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · AG
A new genetic approach for studying prions and other pathogenic protein aggregate
$845,250Ann Hochschild · Harvard Medical School · DP1 · FY2008 · OD
Neural and Biochemical Mechanisms of Cognitive Aging
$845,231William J. Jagust · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2018 · AG
[18F]-PU-AD epichaperome PET imaging probe
$845,131Gabriela Chiosis · Sloan-Kettering Inst Can Research · RF1 · FY2025 · AG
Extracranial Carotid Atherosclerosis Contributions to Cognitive Impairment and Alzheimer's Disease Risk
$844,972Craig C Weinkauf · University Of Arizona · R01 · FY2021 · AG
Targeting Lewy Body Specific Pathology Using Biomarkers
$844,960Karen S Marder · Columbia University Health Sciences · U01 · FY2017 · NS
Genomically rewritten and tailored humanized mouse models for various organ disorders
$844,954Jef D Boeke · New York University School Of Medicine · R24 · FY2025 · OD
Genomic approach to identification of microglial networks involved in Alzheimerâs disease risk
$844,934Alison M Goate · Icahn School Of Medicine At Mount Sinai · U01 · FY2019 · AG
Novel directions for investigating the role of VGF in comorbid Major Depressive Disorder and Alzheimer's disease
$844,931Stephen R Salton · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · AG
Tau, amyloid, & white matter burden interact to impact brain networks in preclinical Alzheimer's disease
$844,917Julius C Hedden · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · AG
Intranasal delivery of VGF-derived peptides in a preclinical model of Alzheimer's disease
$844,721Stephen R Salton · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · AG
Novel Network Biology Approaches to Reposition FDA-approved Drugs for Alzheimer's Disease
$844,721Bin Zhang · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · AG
Noninvasive Low-cost Biomarkers for Preclinical Diagnosis and Longitudinal Tracking of Alzheimer's Disease Using Sleep and Resting State EEG
$844,721Patrick L. Purdon · Massachusetts General Hospital · R01 · FY2018 · AG
Development of a Quantitative Iron Characterization System for Alzheimer's Disease Using Computed Laminography X-ray Fluorescence Imaging (CL-XRFI)
$844,695Wenbing Yun · Sigray, Inc. · R44 · FY2021 · GM
Role of age, dopamine, and tau related network disruption in setting a context for progression toward Alzheimer's disease
$844,657Julius C Hedden · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · AG
Transcriptional Control of Neuroinflammation in Alzheimer's Disease
$844,584Ming-Ming Zhou · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · AG
Contact System and Alzheimer's Disease: Mechanism and Therapeutic Potential
$844,508Sidney Strickland · Rockefeller University · R01 · FY2024 · NS
Contact System and Alzheimer's Disease: Mechanism and Therapeutic Potential
$844,508Sidney Strickland · Rockefeller University · R01 · FY2025 · NS
Transcriptional Control of Neuroinflammation in Alzheimer's Disease
$844,476Ming-Ming Zhou · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · AG
Cognitive Resilience among Older Samoans
$844,445Becca R Levy · Yale University · R01 · FY2021 · AG
Data Core - The State Alzheimer's Research Support Center (StARS)
$844,400Kali St. Marie Thomas · University Of Minnesota · U54 · FY2025 · AG
Clinical Core
$844,290James McCallum Noble · Columbia University Health Sciences · P30 · FY2021 · AG